Ramadevi Subramani Reddy | Cancer Biology | Research Excellence Award

Dr. Ramadevi Subramani Reddy | Cancer Biology | Research Excellence Award

Associate Professor | Texas Tech University Health Sciences Center El Paso | United States

Dr. Ramadevi Subramani Reddy is an Associate Professor at Texas Tech University Health Sciences Center El Paso and a researcher in Cancer Biology with extensive expertise in molecular and translational oncology. She holds advanced training in biochemistry and cancer biology, with doctoral specialization in cancer-related cellular mechanisms, including differentiation, cell cycle regulation, and apoptosis. Her professional experience spans progressive research roles from competitive fellowships to senior research and faculty positions, demonstrating sustained leadership in funded cancer research programs. Her work focuses on molecular signaling pathways, inflammation-mediated cancer progression, and translational strategies for cancer prevention and therapy, resulting in a strong body of peer-reviewed publications with significant citation impact. Dr Reddy has contributed to multidisciplinary research initiatives, mentored trainees, and supported collaborative cancer research efforts. Her career is distinguished by nationally and internationally funded fellowships and research awards that recognize her scientific rigor, consistency, and impact in advancing cancer biology research.

Citation Metrics (Google Scholar)

1732
1200
600
300
0

1732

34

24

Citations

Documents

h-index

Vasileios Alexandros Karakousis | Medicine and Dentistry | Best Researcher Award

Dr. Vasileios Alexandros Karakousis | Medicine and Dentistry | Best Researcher Award

Surgery at Aristotle University of Thessaloniki, Greece

Dr. Vasileios Alexandros Karakousis is a multidisciplinary medical professional with dual degrees in Medicine (MD) and Pharmacy (PharmD), complemented by a Master’s in Clinical and Industrial Pharmacology. He is currently a PhD researcher in Plastic Surgery at the Aristotle University of Thessaloniki and teaches in the postgraduate MSc program in Colorectal Surgery at the University of Thessaly. His research portfolio includes over a dozen peer-reviewed publications in high-impact journals, covering areas such as oncology, immunotherapy, diagnostic imaging, and surgical outcomes. He has also presented at major international conferences across Europe. With clinical training in top hospitals in Greece and France, and fluency in English and French, Dr. Karakousis brings a global perspective to his work. His recent research momentum, coupled with academic and teaching contributions, positions him as a promising early-career researcher making impactful strides in medical science and healthcare.

Professional Profile 

Scopus Profile
ORCID Profile 

Education

Dr. Vasileios Alexandros Karakousis holds an impressive academic background with dual professional degrees. He earned his Doctor of Pharmacy (PharmD) in 2010 and his Doctor of Medicine (MD) in 2017 from the Aristotle University of Thessaloniki (AUTH). He further completed a Master of Science (MSc) in Clinical and Industrial Pharmacology, with a focus on Clinical Toxicology, also from AUTH. Currently, he is pursuing a PhD in Plastic Surgery at Papageorgiou General Hospital, under AUTH’s School of Medicine. His education also includes a European academic exchange through the Erasmus+ Program at Université de Paris. He holds both medical and pharmaceutical licenses from relevant Greek professional bodies. Dr. Karakousis is also multilingual, with certifications in English (C2, University of Michigan) and French (B2, DELF), which enhance his ability to collaborate internationally. His continuous academic development reflects a strong commitment to both scientific inquiry and clinical excellence.

Professional Experience

Dr. Karakousis has cultivated a dynamic professional career across medical, pharmaceutical, and academic domains. He currently teaches in the postgraduate MSc program in Colorectal Surgery at the University of Thessaly, where he contributes to the academic development of future surgeons. His clinical experience spans several prestigious institutions, including AHEPA University Hospital, Ippokrateio Hospital, and hospitals in Paris through externships at Hôpital Saint-Louis and Hôpital Paris Saint-Joseph. His earlier work includes service as a pharmacist in community pharmacies and military medical service at Greek military hospitals. He has also completed a surgical internship and practical training in both hospital and community pharmacy settings. This breadth of experience has shaped him into a well-rounded clinician and academic, capable of bridging pharmaceutical knowledge with surgical and medical practice. His active engagement in multiple clinical environments enhances his ability to apply research insights directly into patient care.

Research Interest

Dr. Karakousis has a broad and evolving set of research interests focused primarily on oncology, surgery, immunology, pharmacology, and diagnostic imaging. His recent research includes systematic reviews, meta-analyses, and case studies in gastrointestinal stromal tumors, medullary thyroid carcinoma, and metastatic colorectal cancer, emphasizing clinical relevance and evidence-based care. He has shown particular interest in cancer immunotherapy, mRNA vaccines, and tumor microenvironment modulation, indicating a forward-looking approach to precision medicine. His work on metaplastic and neuroendocrine breast cancers, as well as rare tumor types, reflects a commitment to addressing under-researched clinical challenges. Additionally, his contributions to diagnostic methodology, such as PET-CT and MRI-endosonography, highlight a keen interest in enhancing preoperative assessment and surgical planning. His multidisciplinary background enables him to pursue translational research that connects pharmacological principles with surgical outcomes and immunological mechanisms, making his academic pursuits both innovative and clinically grounded.

Award and Honor

Dr. Vasileios Alexandros Karakousis has earned recognition through multiple academic and professional achievements, although formal awards are not extensively detailed in the available record. His selection as a presenter at high-level international conferences—including the Joint EWMA-GNEAUPP 2025 Conference in Spain, the 11th Conference of ESES in Turkey, and the 16th Greek-Cypriot Surgical Congress in Cyprus—reflects peer acknowledgment of the quality and significance of his research. He was also a featured presenter at the Scientific Conference of Greek Medical Students, demonstrating early engagement with academic excellence. His role as a lecturer in a postgraduate surgical program further indicates institutional recognition of his expertise. Though not explicitly listed, his numerous peer-reviewed publications in high-impact journals and international collaborations suggest growing influence and respect in the medical research community. These achievements collectively support his eligibility for further awards, including the Best Researcher Award nomination.

Conclusion

Dr. Vasileios Alexandros Karakousis exemplifies the qualities of a promising, multidisciplinary medical researcher. With a robust academic foundation in both medicine and pharmacy, he combines clinical expertise with scientific rigor. His professional journey includes hands-on roles in pharmacy, surgery, teaching, and international externships, highlighting his versatility and dedication to improving healthcare. His recent surge in impactful research—covering oncology, diagnostics, pharmacology, and immunotherapy—demonstrates a forward-thinking, evidence-based approach that resonates with current global healthcare priorities. As a multilingual academic with international experience, he is well-positioned for collaboration and leadership in cross-border research initiatives. While his career is still in a growth phase, his academic trajectory, research contributions, and teaching involvement underscore his potential to make lasting contributions to medical science. Based on his achievements and promise, Dr. Karakousis is a compelling candidate for recognition such as the World Top Scientists Best Researcher Award.

Publications Top Notes

  • Multifocal Gastrointestinal Stromal Tumors (GISTs) of the Small Intestine in Patients with Neurofibromatosis Type 1 (NF-1): Meta‑Analysis and Systematic Review of the Literature

    • Authors: Stylianos Mantalovas; Vasileios Alexandros Karakousis; Christina Sevva; Panagiota Roulia; Stavros Savvakis; Georgios Anthimidis; Konstantinos Papadopoulos; Vasiliki Magra; Nikolaos Varsamis; Christoforos S. Kosmidis; et al.

    • Year: 2025

  • The Efficacy of Positron Emission Tomography/Computed Tomography Scan (PET CT) in the Diagnosis of Local Recurrence and Metastases in Surgical Patients with Medullary Thyroid Carcinoma: A Systematic Review and Meta‑Analysis of the Last 5 Years (2020–2024)

    • Authors: Konstantinos Papadopoulos; Ioannis Iakovou; Stylianos Mantalovas; Christoforos S. Kosmidis; Stiliani Laskou; Vasileios Alexandros Karakousis; Christina Sevva; Marios Dagher; Panagiota Roulia; Ismini Kountouri; et al.

    • Year: 2024

  • Streamline Flow of the Portal Vein Affects the Distribution of Colorectal Cancer Metastases: Clinical Reality or Just a Belief? A Systematic Review and Meta‑Analysis

    • Authors: Stavros Savvakis; Vasileios I. Lagopoulos; Stylianos Mantalovas; Eleni Paschou; Periklis Kopsidas; Christina Sevva; Alexandros Vasileios Karakousis; Eleni Gigi; Isaak Kesisoglou

    • Year: 2024

  • A 78‑Year‑Old Man with Elastofibroma Dorsi Presenting as a Left Subscapular Mass

    • Authors: Christoforos S. Kosmidis; Konstantinos Vlassopoulos; Chrysi Maria Mystakidou; Vasiliki Theodorou; Alexandros Vasileios Karakousis; Nikolaos Iason Katsios; Fedra Louloudopoulou; Anna Andreadi; Paris Pentousis; Stylianos Mantalovas; et al.

    • Year: 2024

  • Neuroendocrine Breast Carcinoma: Interesting Images of an Underdiagnosed Entity

    • Authors: Christoforos Kosmidis; Kassiani Boulogeorgou; Panagiota ___; Marios Dagher; Georgios Anthimidis; Georgios Petrakis; Charilaos Koulouris; Stylianos Mantalovas; Styliani Laskou; Vasiliki Magra; et al.

    • Year: 2024

  • Immune‑Specific and Tumor‑Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy

    • Authors: Theodora Katopodi; Savvas Petanidis; Eirini Grigoriadou; Doxakis Anestakis; Charalampos Charalampidis; Ioanna P. Chatziprodromidou; George Floros; Panagiotis Eskitzis; Paul Zarogoulidis; Charilaos Koulouris; et al. (includes V. A. Karakousis)

    • Year: 2024

  • Metaplastic Breast Carcinoma – A Rare Subtype of Breast Cancer that Poses a Challenge to Treatment: 2 Case Reports and Review of the Literature

    • Authors: Vasiliki Magra; Sofia Baka; Eleni Georgakoudi; Vasiliki Theodorou; Chrysi Maria Mystakidou; Evanthia Papadopoulou; Alexandros Karakousis; Petrina Miltiadous; Georgios Anthimidis; Christoforos Kosmidis

    • Year: 2024

  • Tumor Cell Metabolic Reprogramming and Hypoxic Immunosuppression: Driving Carcinogenesis to Metastatic Colonization

    • Authors: Theodora Katopodi; Savvas Petanidis; Doxakis Anestakis; Charalampos Charalampidis; Ioanna Chatziprodromidou; George Floros; Panagiotis Eskitzis; Paul Zarogoulidis; Charilaos Koulouris; Christina Sevva; et al.

    • Year: 2024

  • Acute Gangrenous Appendicitis in a 70‑Year‑Old Patient with Multiple Myeloma

    • Authors: (Not fully listed); Vasileios Alexandros Karakousis included.

    • Year: 2024

  • Preoperative Assessment of Perianal Fistulas with Combined Magnetic Resonance and Three-Dimensional Endoanal Ultrasound: A Prospective Study

    • Authors: Nikolaos Varsamis; Christoforos Kosmidis; Grigorios Chatzimavroudis; Fani Apostolidou Kiouti; Christoforos Efthymiadis; Vasilis Lalas; Chrysi Maria Mystakidou; Christina Sevva; Konstantinos Papadopoulos; Georgios Anthimidis; et al.

    • Year: 2023

  • Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration

    • Authors: Vasileios Alexandros Karakousis; Danai Liouliou; Aikaterini Loula; Nikoleta Kagianni; Eva‑Maria Dietrich; Soultana Meditskou; Antonia Sioga; Theodora Papamitsou

    • Year: 2020

  • Potential Drug–Drug Interactions in Prescriptions Dispensed in Community Pharmacies in Greece

    • Authors: Anna Chatsisvili; Ioakeim Sapounidis; Georgia Pavlidou; Eudoxia Zoumpouridou; Vasileios‑Alexandros Karakousis; Marios Spanakis; Lefteris Teperikidis; Ioannis Niopas

    • Year: 2010

Chenjing Zhu | Oncology | Best Researcher Award

Dr. Chenjing Zhu | Oncology | Best Researcher Award

Associate professor, Jiangsu Cancer Hospital, China

Cenjing Zhu is a dedicated medical professional specializing in radiation oncology at Jiangsu Cancer Hospital, Nanjing, China. With a strong background in clinical research and cancer treatment, she has made significant contributions to understanding cancer biology and therapeutic strategies. Dr. Zhu has a keen interest in advancing medical science through research, education, and clinical excellence. 🌟💉

Publication Profile

ORCID

Education

Dr. Zhu completed her Bachelor of Medicine (2011-2016) and M.D. (2016-2019) from the West China School of Medicine, Sichuan University, Chengdu, China. Her academic journey in the field of medicine has paved the way for her expertise in oncology and cancer research. 🎓📚

Experience

Since 2019, Dr. Zhu has been a part of the Department of Radiation Oncology at Jiangsu Cancer Hospital, where she contributes to both clinical care and scientific research. Her leadership in cancer research and clinical innovation is well-recognized within the medical community. 🏥💼

Research Focus

Dr. Zhu’s research primarily revolves around cancer therapeutics, focusing on the AXL receptor tyrosine kinase as an anti-cancer approach, psychological distress in cancer patients, and innovative diagnostic techniques in oncology. She is particularly interested in tumor microenvironment modulation and the application of advanced imaging techniques in cancer treatment. 🔬🧬

Awards and Honors

Throughout her career, Dr. Zhu has been invited to present her work at prestigious international conferences, including the World Congress on Advances in Oncology and the International Symposium on Molecular Medicine. Her research excellence has garnered recognition and invitations to prominent platforms for cancer research and molecular medicine. 🏆🌍

Publication Top Notes

Zhu’s influential article on AXL receptor tyrosine kinase as a promising anti-cancer approach, Molecular Cancer 2019, has reshaped clinical strategies, cited extensively.

Her 2020 study on dual MET/AXL inhibitors in gastric carcinoma, published in MedComm, offers groundbreaking insights into tumor microenvironment modulation.

Zhu’s 2024 research in BMC Psychol on psychological distress in Chinese cancer patients demonstrates the importance of mental health during cancer treatment.

Her 2024 review of circulating microRNAs as diagnostic biomarkers for cervical cancer in Discov Oncol continues to shape diagnostic research in oncology